Drug intelligence / Profile preview

platelet-rich plasma (Regen Lab)

Development stage
Unknown
Lead developer
Regen Lab
Modality
Cell Therapies
Administration
Intramuscular, Intraarticular, Subcutaneous, Topical
01

Overview

RegenLab PRP refers to a range of autologous platelet-rich plasma (PRP) preparation systems developed by Regen Lab SA. The technology utilizes specialized vacuum tubes containing a proprietary thixotropic separator gel to isolate platelets and plasma from whole blood while removing pro-inflammatory red blood cells and granulocytes. Upon administration, the concentrated platelets undergo activation, releasing a concentrated cocktail of endogenous growth factors—including Platelet-Derived Growth Factor (PDGF), Transforming Growth Factor-beta (TGF-β), and Vascular Endothelial Growth Factor (VEGF). These factors stimulate cellular proliferation, angiogenesis, and extracellular matrix synthesis, facilitating tissue repair and regeneration. It is primarily indicated for musculoskeletal conditions like osteoarthritis and tendinopathies, as well as in aesthetic medicine for skin rejuvenation and the treatment of androgenetic alopecia.

Brand names
RegenLab PRPRegenKit-PRPCellular MatrixRegenPRP
Other names
PRPautologous platelet-rich plasmaplatelet-rich plasma

Beyond the preview

Go deeper on platelet-rich plasma (Regen Lab).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on platelet-rich plasma (Regen Lab).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call